Murphy Christopher | Activbiotics Inc.
スポンサーリンク
概要
関連著者
-
Murphy Christopher
Activbiotics Inc.
-
Rothstein David
Activbiotics Inc.
-
ROTHSTEIN David
ActivBiotics, Inc.
-
OSBURNE Marcia
ActivBiotics Inc.
-
MURPHY Christopher
ActivBiotics, Inc.
-
Murphy Christopher
米国
-
Van Duzer
Activbiotics Inc.
-
MULLIN Steve
ActivBiotics, Inc.
-
SIROKMAN Klari
Gwathmey Inc.
-
SONDERGAARD Karen
Gwathmey Inc.
-
JOHNSON Starrla
Gwathmey Inc.
-
GWATHMEY Judith
Gwathmey Inc.
-
Mullin Steve
Activbiotics Inc.
-
KARGINOVA Elena
Eurofins Medinet, Inc.
-
SAHM Dan
Eurofins Medinet, Inc.
-
Sahm Dan
Eurofins Medinet Inc.
-
Karginova Elena
Eurofins Medinet Inc.
-
SUCHLAND Robert
Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington
-
XIA Minsheng
Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington
-
STAMM Walter
Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington
-
Xia Minsheng
Division Of Allergy And Infectious Diseases Department Of Medicine University Of Washington
-
Suchland Robert
Division Of Allergy And Infectious Diseases Department Of Medicine University Of Washington
-
Stamm Walter
Division Of Allergy And Infectious Diseases Department Of Medicine University Of Washington
-
FARQUHAR Ronnie
ActivBiotics Inc.
-
Rothstein David
米国
著作論文
- Rifalazil and Derivative Compounds Show Potent Efficacy in a Mouse Model of H. pylori Colonization
- In Vitro Activity of Novel Rifamycins against Gram-positive Clinical Isolates
- Rifalazil Retains Activity Against Rifampin-resistant Mutants of Chlamydia pneumoniae
- Enhanced Activity of Rifalazil in Combination with Levofloxacin, Linezolid, or Mupirocin against Staphylococcus aureus In Vitro
- In Vitro Time-kill Activities of Rifalazil, Alone and in Combination with Vancomycin, against Logarithmic and Stationary Cultures of Staphylococcus aureus